Results 231 to 240 of about 86,495 (277)

Local and Systemic Effects of Chronic Intracavernous Injection of Papaverine, Prostaglandine E1 and Saline in Primates [PDF]

open access: yes, 1989
Aboseif, Sherif R.   +7 more
core  

Invasive Bladder Cancer With Peritoneal Invasion and Rectal Involvement Causing Rectal, Bilateral Ureteral, and Common Bile Duct Obstruction Without a Retroperitoneal Mass: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Bladder cancer (BC) is rarely associated with common bile duct (CBD) obstruction. We report a case of BC with peritoneal invasion and rectal involvement complicated by bilateral ureteral and biliary obstruction. Case Presentation A 77‐year‐old man presented with abdominal pain.
Kazuto Imai   +6 more
wiley   +1 more source

A Case of Bilateral Renal Cancer in a Dialysis Patient With Enlarged ACDK Treated With Staged Laparoscopic Nephrectomy

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction End‐stage renal disease (ESRD) patients have a high risk of Acquired Cystic Disease‐associated Renal Cell Carcinoma (ACD‐RCC) due to chronic inflammation and cystic renal atrophy. Although laparoscopic radical nephrectomy (LRN) is standard, massively enlarged kidneys may increase surgical difficulty.
Rintaro Yoshitake   +4 more
wiley   +1 more source

Virtual Screening of Phytochemicals From Medicinal Plants as Promising PDE5 Inhibitors Against Erectile Dysfunction. [PDF]

open access: yesFood Sci Nutr
Boudou F   +7 more
europepmc   +1 more source

Pituitary Apoplexy Following Gonadotropin‐Releasing Hormone Agonist Administration for Prostate Cancer

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Pituitary apoplexy represents an uncommon endocrine emergency with potentially life‐threatening consequences. Gonadotropin‐releasing hormone agonist used for prostate cancer has the potential to induce pituitary apoplexy, particularly in the setting of a preexisting pituitary adenoma.
Masaaki Fujimura   +5 more
wiley   +1 more source

Serum LDL level as an indirect marker of erectile dysfunction in male CAD patients. [PDF]

open access: yesJ Family Med Prim Care
Gupta H   +4 more
europepmc   +1 more source

Complete Response to Pembrolizumab After Progression on Avelumab Maintenance in Metastatic Urothelial Carcinoma

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Avelumab maintenance after response to platinum chemotherapy improves outcomes in metastatic urothelial carcinoma. Progression during maintenance presents a therapeutic dilemma. Case Presentation A 72‐year‐old man underwent radical cystectomy and left nephroureterectomy for high‐grade urothelial carcinoma.
Fumihiro Ito   +4 more
wiley   +1 more source

Apalutamide‐Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Apalutamide (APA) is an androgen receptor signaling inhibitor widely used for metastatic hormone‐sensitive prostate cancer (mHSPC), though it can induce hypothyroidism. We report a severe case of APA‐induced hypothyroidism in a patient with a history of total thyroidectomy.
Jun Furumido   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy